⌘K

Login Start Free

Home/Filings/4/0001209191-21-008631

4//SEC Filing

DENYES NANCY 4

Accession 0001209191-21-008631

CIK 0001339970other

View on SEC.gov Company Profile

Filed

Feb 7, 7:00 PM ET

Accepted

Feb 8, 8:13 PM ET

Size

5.6 KB

Accession

0001209191-21-008631

Insider Transaction Report

Form 4

Period: 2021-02-04

aTYR PHARMA INCLIFE

General Counsel

Transactions

Award
Employee Stock Option (right to buy)
2021-02-04+45,000→ 45,000 total
Exercise: $4.52Exp: 2031-02-04→ Common Stock (45,000 underlying)

Footnotes (1)

[F1]The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning March 4, 2021, such that this option will be fully exercisable on February 4, 2025. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

aTYR PHARMA INC

CIK 0001339970

Entity typeother

Related Parties

1

filerCIK 0001640869

Filing Metadata

Form type: 4
Filed: Feb 7, 7:00 PM ET
Accepted: Feb 8, 8:13 PM ET
Size: 5.6 KB

View on SEC.gov